Research on TCM Characteristic Payment Method Based on Decision Tree Model——Taking Colorectal Cancer as an Example

China Health Insurance ›› 2024, Vol. 0 ›› Issue (4) : 35-40.

China Health Insurance ›› 2024, Vol. 0 ›› Issue (4) : 35-40. DOI: 10.19546/j.issn.1674-3830.2024.4.005
Observation & Discussion

Research on TCM Characteristic Payment Method Based on Decision Tree Model——Taking Colorectal Cancer as an Example

Author information +
History +

Abstract

Objective: Taking inpatients with colorectal cancer as an example, the paper explores a suitable medical insurance payment method for traditional Chinese medicine (TCM) medical institutions. Methods: 28083 cases of colorectal malignant tumors were selected from the medical records of inpatients from some TCM and comprehensive hospitals in Beijing in 2021. Non-parametric testing and multiple linear regression analysis were used to determine the influencing factors of hospitalization costs, and decision tree model was used to construct the grouping plan. Results: 8 influencing factors, including surgery, number of diagnoses and the proportion of TCM treatment costs, were included as classification nodes in the decision tree model to form 12 case groups. The CV and RIV values showed good grouping results. Conclusion: By incorporating the indicator "proportion of TCM treatment costs" representing the characteristics of TCM as a classification node into the grouping model, a treatment grouping plan for colorectal cancer that reflects the characteristics of TCM can be obtained, which can provide a reference for establishing medical insurance payment methods suitable for TCM medical institutions.

Key words

TCM characteristics / medical insurance payment method / colorectal cancer / decision tree

Cite this article

Download Citations
Research on TCM Characteristic Payment Method Based on Decision Tree Model——Taking Colorectal Cancer as an Example[J]. China Health Insurance. 2024, 0(4): 35-40 https://doi.org/10.19546/j.issn.1674-3830.2024.4.005

References

[1] 张弘,丁科,谢俊明,等.“疗效价值付费”下的中医优势病种DRG付费方案探索[J].卫生经济研究,2021,38(12):75-76+79.
[2] 宋桂杭,刘志新,杨仁前.DRG/DIP付费下开展中医优势病种的政策思考[J].中国医疗保险, 2023(07): 23-29.
[3] 赵逸赫,袁全,任雅薇.上海试点中医优势病种“按疗效价值付费”[N].经济参考报,2022-11-02(006).
[4] 北京市卫生健康委员会.2021年北京卫生健康年鉴[M].北京:北京科技出版社,2021.
[5] 杨宇飞.中医药在结直肠癌治疗中的优势与展望[J].中国中西医结合,2020,40(11):1294-1297.
[6] 郭慧君,杨宇飞,易丹辉,等.某市中医医院与综合医院恶性肿瘤化疗患者住院费用结构对比分析[J].中国病案,2022,23(9):77-80.
[7] 代紫璇,刘黎明,蒋艳,等.基于决策树模型的中医优势病种病例组合研究——以脑梗死为例[J].中国医疗保险,2023,(04):19-24.
[8] 濮洋,王滢鹏,万彬,等.肺大手术病组费用影响因素及病例组合研究[J].中国医疗保险,2023(8):116-121.
[9] 谢冰珏,佘颖,唐路,等.基于决策树模型的DRG优化分组探索——以新生儿疾病外科组为例[J].卫生经济研究,2023,40(02): 47-51.
[10] 周鹏飞,杨孝光,路强,等.恶性肿瘤术后化疗住院患者DRG分组研究——基于E-CHAID算法[J].卫生经济研究,2023,40(06):35-39+43.
[11] 闫晓婧,于丽华,周海龙,等.恶性肿瘤药物治疗的DRG分组方案研究[J].中国卫生经济,2021,40(07):40-43.
[12] 王锦毓,袁波英,杨永挺.基于决策树模型的不同放疗方式对住院费用影响因素分析[J].中国病案,2022,23(03):50-53.
[13] 林卓琛,辛子艺,熊莺.运用决策树模型对某医院不稳定型心绞痛住院费用的分析[J].中国病案,2023,24(8):60-64.
[14] 国家医疗保障局.国家医疗保障疾病诊断相关分组(CHS-DRG)分组与付费技术规范[EB/OL].(2019-10-24)[2022-07-05].http://www.nhsa.gov.cn/art/2019/10/24/art_37_1878.html.
[15] 于磊,吴佳勉,熊小兰,等.基于DRG的急性心肌梗死患者分组效果评价与费用分析[J].卫生经济研究,2021,38(10):35-39.
[16] 朱小颖,田侃,吴文忠,等.我国中医医院DRG付费若干问题与对策探讨[J].中国医院,2022,26(5):10-12.

Accesses

Citation

Detail

Sections
Recommended

/